The effects of type 1 diabetes on cerebral white matter

K. Weinger; A. M. Jacobson; G. Musen; I. K. Lyoo; C. M. Ryan; D. C. Jimerson; P. F. Renshaw

doi:10.1007/s00125-007-0904-9

The effects of type 1 diabetes on cerebral white matter

K. Weinger, A. M. Jacobson, G. Musen, I. K. Lyoo, C. M. Ryan, D. C. Jimerson, P. F. Renshaw

Department of Pharmaceutical Sciences

Research output: Contribution to journal › Article › peer-review

64 Scopus citations

Abstract

Aim/hypothesis: Studies investigating the structure, neurophysiology and functional outcomes of white matter among type 1 diabetes patients have given conflicting results. Our aim was to investigate the relationship between type 1 diabetes and white matter hyperintensities. Method: We assessed white matter integrity (using magnetic resonance imaging), depressive symptoms and neuropsychological function in 114 type 1 diabetes patients and 58 age-matched non-diabetic controls. Results: Only Fazekas grade 1 and 2 white matter hyperintensities were found among 114 long-duration, relatively young diabetes patients; the severity of lesions did not differ substantially from 58 healthy controls. White matter hyperintensities were not associated with depressive history or with clinical characteristics of diabetes, including retinopathy, severe hypoglycaemia or glycaemia control. Conclusions/interpretation: Our data do not support an association between diabetes characteristics and white matter hyperintensities among relatively young type 1 diabetes participants.

Original language	English
Pages (from-to)	417-425
Number of pages	9
Journal	Diabetologia
Volume	51
Issue number	3
DOIs	https://doi.org/10.1007/s00125-007-0904-9
State	Published - Mar 2008

Bibliographical note

Funding Information:
Acknowledgements This research was supported by NIDDK R01060754 (A. M. Jacobson), the Herbert Graetz Fund, and in part by the Diabetes and Endocrinology Research Core NIH P30 DK36836, and in part by grant RR 01032 to the Beth Israel Deaconess Medical Center General Clinical Research Center. We thank C. Sparks and A. Burwood for their invaluable assistance in participant recruitment and study organisation.

Keywords

Brain structure
Cognition
MRI
Neuroimaging
Type 1 diabetes
White matter hyperintensities

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00125-007-0904-9

Cite this

@article{a38752d7e5424738ad6efaa2e8372bf7,

title = "The effects of type 1 diabetes on cerebral white matter",

abstract = "Aim/hypothesis: Studies investigating the structure, neurophysiology and functional outcomes of white matter among type 1 diabetes patients have given conflicting results. Our aim was to investigate the relationship between type 1 diabetes and white matter hyperintensities. Method: We assessed white matter integrity (using magnetic resonance imaging), depressive symptoms and neuropsychological function in 114 type 1 diabetes patients and 58 age-matched non-diabetic controls. Results: Only Fazekas grade 1 and 2 white matter hyperintensities were found among 114 long-duration, relatively young diabetes patients; the severity of lesions did not differ substantially from 58 healthy controls. White matter hyperintensities were not associated with depressive history or with clinical characteristics of diabetes, including retinopathy, severe hypoglycaemia or glycaemia control. Conclusions/interpretation: Our data do not support an association between diabetes characteristics and white matter hyperintensities among relatively young type 1 diabetes participants.",

keywords = "Brain structure, Cognition, MRI, Neuroimaging, Type 1 diabetes, White matter hyperintensities",

author = "K. Weinger and Jacobson, {A. M.} and G. Musen and Lyoo, {I. K.} and Ryan, {C. M.} and Jimerson, {D. C.} and Renshaw, {P. F.}",

note = "Funding Information: Acknowledgements This research was supported by NIDDK R01060754 (A. M. Jacobson), the Herbert Graetz Fund, and in part by the Diabetes and Endocrinology Research Core NIH P30 DK36836, and in part by grant RR 01032 to the Beth Israel Deaconess Medical Center General Clinical Research Center. We thank C. Sparks and A. Burwood for their invaluable assistance in participant recruitment and study organisation.",

year = "2008",

month = mar,

doi = "10.1007/s00125-007-0904-9",

language = "English",

volume = "51",

pages = "417--425",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Verlag",

number = "3",

}

TY - JOUR

T1 - The effects of type 1 diabetes on cerebral white matter

AU - Weinger, K.

AU - Jacobson, A. M.

AU - Musen, G.

AU - Lyoo, I. K.

AU - Ryan, C. M.

AU - Jimerson, D. C.

AU - Renshaw, P. F.

N1 - Funding Information: Acknowledgements This research was supported by NIDDK R01060754 (A. M. Jacobson), the Herbert Graetz Fund, and in part by the Diabetes and Endocrinology Research Core NIH P30 DK36836, and in part by grant RR 01032 to the Beth Israel Deaconess Medical Center General Clinical Research Center. We thank C. Sparks and A. Burwood for their invaluable assistance in participant recruitment and study organisation.

PY - 2008/3

Y1 - 2008/3

N2 - Aim/hypothesis: Studies investigating the structure, neurophysiology and functional outcomes of white matter among type 1 diabetes patients have given conflicting results. Our aim was to investigate the relationship between type 1 diabetes and white matter hyperintensities. Method: We assessed white matter integrity (using magnetic resonance imaging), depressive symptoms and neuropsychological function in 114 type 1 diabetes patients and 58 age-matched non-diabetic controls. Results: Only Fazekas grade 1 and 2 white matter hyperintensities were found among 114 long-duration, relatively young diabetes patients; the severity of lesions did not differ substantially from 58 healthy controls. White matter hyperintensities were not associated with depressive history or with clinical characteristics of diabetes, including retinopathy, severe hypoglycaemia or glycaemia control. Conclusions/interpretation: Our data do not support an association between diabetes characteristics and white matter hyperintensities among relatively young type 1 diabetes participants.

AB - Aim/hypothesis: Studies investigating the structure, neurophysiology and functional outcomes of white matter among type 1 diabetes patients have given conflicting results. Our aim was to investigate the relationship between type 1 diabetes and white matter hyperintensities. Method: We assessed white matter integrity (using magnetic resonance imaging), depressive symptoms and neuropsychological function in 114 type 1 diabetes patients and 58 age-matched non-diabetic controls. Results: Only Fazekas grade 1 and 2 white matter hyperintensities were found among 114 long-duration, relatively young diabetes patients; the severity of lesions did not differ substantially from 58 healthy controls. White matter hyperintensities were not associated with depressive history or with clinical characteristics of diabetes, including retinopathy, severe hypoglycaemia or glycaemia control. Conclusions/interpretation: Our data do not support an association between diabetes characteristics and white matter hyperintensities among relatively young type 1 diabetes participants.

KW - Brain structure

KW - Cognition

KW - MRI

KW - Neuroimaging

KW - Type 1 diabetes

KW - White matter hyperintensities

UR - http://www.scopus.com/inward/record.url?scp=39049095119&partnerID=8YFLogxK

U2 - 10.1007/s00125-007-0904-9

DO - 10.1007/s00125-007-0904-9

M3 - Article

C2 - 18157661

AN - SCOPUS:39049095119

SN - 0012-186X

VL - 51

SP - 417

EP - 425

JO - Diabetologia

JF - Diabetologia

IS - 3

ER -

The effects of type 1 diabetes on cerebral white matter

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this